This brand name is authorized in Nigeria. It is also authorized in Romania.
The drug ESSENTIALE contains one active pharmaceutical ingredient (API):
1
|
UNII
1DI56QDM62 - LECITHIN, SOYBEAN
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
04-1553 | Capsule | Essentiale Forte 300 mg Capsules CAP 300 mg 50's | Each capsule contains: De-Oiled Enriched Phospholipids from Soya Beans 300 mg | 03/08/2021 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
A05BA | Liver therapy | A Alimentary tract and metabolism → A05 Bile and liver therapy → A05B Liver therapy, lipotropics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | 04-1553 |
RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W68002001, W68002002, W68003001, W68003002, W68003003 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.